No Need to Speculate: Ontario Court of Appeal Affirms Denial of Certification in Pharmaceutical Product Liability Class Action Based on Increased Risk of Harm


Can consumers subject to an increased risk of harm from a product successfully certify a product liability class action even though the harm has not yet, and may never, come to pass? In Palmer v Teva Canada Limited, the Ontario Court of Appeal recently confirmed the answer is no.1

Background to the Case and Denial of Certification

In the certification decision, covered by our team in a previous article, the Ontario Superior Court of Justice denied certification of the plaintiffs’ proposed class action due primarily to the nature of the damages sought by the proposed class members.2

More Information

For more information, please contact the authors of this article or any member of the Product Liability Group.